Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo

Archives of Virology

Volumn 152, Issue 8, 2007, Pages 1447-1455

  Shi, L ^a   Xiong, H ^a   He, J ^a   Deng, H ^a   Li, Q ^a   Zhong, Q ^a   Hou, W ^a   Cheng, L ^a   Xiao, H ^a   Yang, Z ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ARBIDOL; INDOLE DERIVATIVE;

ADENOVIRUS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; DRUG EFFECT; ENTEROVIRUS; FEMALE; HUMAN; INFLUENZA VIRUS A H1N1; MICROBIOLOGICAL EXAMINATION; MORTALITY; MOUSE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; RHINOVIRUS; RNA VIRUS; TREATMENT OUTCOME; VIROLOGY; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; ENTEROVIRUS B, HUMAN; FEMALE; HUMANS; INDOLES; INFLUENZA A VIRUS, H1N1 SUBTYPE; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS; RHINOVIRUS; RNA VIRUSES; TREATMENT OUTCOME; VIRUS DISEASES;

ADENOVIRIDAE; COXSACKIEVIRUS; DNA VIRUSES; HUMAN ADENOVIRUS TYPE 7; HUMAN RHINOVIRUS 14; HUMAN RHINOVIRUS SP.; INFLUENZA A VIRUS; INFLUENZAVIRUS A; MUS; RESPIRATORY SYNCYTIAL VIRUS; RHINOVIRUS; RICE STRIPE VIRUS; RNA VIRUSES;

EID: 34547209215     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-007-0974-5     Document Type: Article

References (34)

1. Anonymous 1999 Arbidol Drugs R&D 2 171 172
2. YS Boriskin EI Pecheur SJ Polyak 2006 Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection Virol J 3 56
3. MJ Brooks JJ Sasadeusz GA Tannock 2004 Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline? Pulmonary Med 10 197 203
4. RA Burger JL Billingsley JH Huffman KW Bailey CU Kim 2000 Immunological effects of the orally administered neuraminidase inhibitor oseltamivir in influenza virus-infected and uninfected mice Immunopharmacology 47 45 52
5. H Chai Y Zhao C Zhao P Gong 2006 Synthesis and in vitro anti-hepatitis B virus activities of some ethyl-6-bromo-5-hydroxy-1H-indole-3-carboxylates Bioorg Med Chem 14 911 917
6. IT Fedyakina IA Lenyova SS Yamnikova RG Glushkov 2005 Sensitivity of influenza A/H5 viruses isolated from wild birds on the territory of Russia to arbidol in the cultured MDCK cells Vopr Virusol 50 32 35
7. DM Fleming KW Cross 1993 Respiratory syncytial virus or influenza Lancet 324 1507 1510
8. A Garozzo CC Cutri A Castro G Tempera F Guerrera MC Sarva E Geremia 2000 Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives Antiviral Res 45 199 210
9. JE Gern WW Busse 1999 Association of rhinovirus infections with asthma Clin Microbiol Rev 12 9 18
10. TA Guskova IA Leneva IT Fedyakina VV Chistyakov RG Glushkov 1999 Arbidol kinetics and its effect on influenza A virus replication in MDCK cell culture Chemico Pharmaceut J 6 14 17
11. FG Hayden RL Atmar M Schilling C Johnson D Poretz D Paar L Huson P Ward RG Mills 1999 Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza N Engl J Med 341 1336 1343
12. FG Hayden RB Belshe C Villaneueva R Lanno C Hughes I Small R Dutkowski P Ward J Carr 2004 Management of influenza in households: a prospective randomized comparison of oseltamivir treatment with or without post-exposure prophylaxis J Infect Dis 189 440 449
13. L Kaiser C Wat T Mills P Mahoney P Ward F Hayden 2003 Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations Arch Intern Med 163 1667 1672
14. M Kiso K Mitamura Y Sakai-Tagawa K Shiraishi C Kawakami K Kimura F Hayden N Sugaya Y Kawaoka 2004 Resistant influenza A viruses in children treated with oseltamivir: descriptive study Lancet 364 759 765
15. MCJ Kneyber HA Moll RD Groot 2000 Treatment and prevention of respiratory syncytial virus infection Eur J Pediatr 159 399 411
16. Leneva IA, Fedyakina IT, Fadeeva NI, Guskova TA (1996) Effect of a new antiviral drug arbidol on influenza virus replication. Xth International Congress of Virology Aug: 11-16
17. IA Leneva A Hay 1998 The mechanism of action of arbidol against influenza virus: selection and characterization of arbidol-resistant mutants Antiviral Res 37 89
18. Yaolan Li PH Paul 2005 Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Fordin Antiviral Res 68 1 9
19. RS Maitreyi S Broor SK Kabra 2000 Rapid detection of respiratory viruses by centrifugation enhanced cultures from children with acute lower respiratory tract infections J Clin Virol 16 41 47
20. W Markland TJ Mcquaid J Jain AD Kwong 2000 Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon Antimicro Agents Chemother 44 859 866
21. NJ Marshall CJ Goodwin SJ Holt 1995 A critical assessement of the use of microculture tetrazolium assays to measure cell growth and function Growth Regulation 5 69 84
22. H Monobe T Ishibashi Y Nomura M Shinogami J Yano 2003 Role of respiratory viruses in children with acute otitis media Int J Pediatr Otorhinolaryngol 67 801 806
23. T Mosmann 1983 Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays J Immunol Methods 65 55 63
24. FM Munoz GJ Galasso JM Gwaltney FG Hayden B Murphy R Webster P Wright RB Couch 2000 Current research on influenza and other respiratory viruses: II. International Symposium Antiviral Res 46 91 124
25. NG Papadopoulos PJ Bates PG Bardin A Papi SH Leir DJ Fraenkel 2000 Rhinoviruses infect the lower airways J Infect Dis 181 1875 1884
26. DD Patel A Kapoor A Ayyagari TN Dhole 2004 Development of a simple restriction fragment length polymorphism assay for subtyping of coxsackie B viruses J Virol Methods 120 167 172
27. LJ Reed HA Muench 1938 A simple method of estimating fifty percent endpoints Am J Hyg 27 493 497
28. J Schulman 1968 Effect of L-amantanamine hydrochloride(amantadine HCL) and methyl-L-adamantanethylamine hydrochloride (rimantadine HCL) on teansmission of influenza virus infection in mice Proc Soc Exp Biol Med 128 1173 1178
29. K Sudo Y Miyazaki N Kojima M Kobayashi H Suzuki M Shintani Y Shimizu 2005 YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action Antiviral Res 65 125 131
30. WW Thompson DK Shay E Weintraub L Brammer N Cox LJ Anderson K Fukuda 2003 Mortality associated with influenza and respiratory syncytial virus in the United States JAMA 289 179 186
31. World Health Organization (WHO) (2004) World Health Organization: Influenza. http://www.who.int/mediacentre/factsheets/2003/fs211/en/
32. PR Wyde 1998 Respiratory syncytial virus (RSV) disease and prospects for its control Antiviral Res 39 63 79
33. X Xiang D Qiu KP Chan SH Chan RG Hegele WC Tan 2002 Comparison of three methods for respiratory virus detection between induced sputum and nasopharyngeal aspirate specimens in acute asthma J Virol Methods 101 127 133
34. VV Zarubaev AV Slita VZ Krivitskaya AK Sirotkin AL Kovalenko NK Chatterjee 2003 Direct antiviral effect of cycloferon (10-carboxymethyl-9- acridanone) against adenovirus type 6 in vitro Antiviral Res 58 131 137